EUVIMEDEUVIMED entdecken
Crossref

Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives

Ryosuke Kuribayashi, Ayuki Nakano, Miya Kawasaki, Aya Hariu, Akira Sakurai

Trends in Biotechnology · 2026-11

DOI: 10.1016/j.tibtech.2026.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Ryosuke Kuribayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan; Off…. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent Pharmaceuticals and Medical Devices Agency initiatives for live biotherapeutic products, fecal microbiota transplantation, and phage therapy medicinal products illustrate a dialog-driven regulatory approach for microbiome-based medicines. We compare this strategy with evolving Food and Drug Administration and European Medicines Agency frameworks and identify priorities for future regulatory development and international alignment.

Schlagwörter

Stichwörter der Autor:innen

PMDAfecal microbiota transplantationlive biotherapeutic productmicrobiome-based drug developmentphage therapy medicinal product

Autor:innen und Institutionen

  • Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan; Office of Regulatory Science Research, Pharmaceuticals and Medical Device…
  • Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan.

Zitieren

APA

Kuribayashi, R., Nakano, A., Kawasaki, M., Hariu, A., & Sakurai, A. (2026). Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.10.007

Vancouver

Kuribayashi R, Nakano A, Kawasaki M, Hariu A, Sakurai A. Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.10.007

BibTeX
@article{Kuribayashi2026,
  author = {Kuribayashi, Ryosuke and Nakano, Ayuki and Kawasaki, Miya and Hariu, Aya and Sakurai, Akira},
  title = {Regulatory science for microbiome-based medicines: lessons from Pharmaceuticals and Medical Devices Agency initiatives},
  journal = {Trends in Biotechnology},
  year = {2026},
  doi = {10.1016/j.tibtech.2026.10.007}
}
Kostenlos starten →